🇺🇸

US SEC Filing Intelligence

· daily

New Federal Contractors — May 21, 2026

This digest covers five civilian government contracts totaling $755.9 million, all awarded by non-Defense agencies, with zero defense-related exposure. The dominant theme is Health and Human Services (HHS) spending, accounting for four of five contracts and $685.3 million (91%) of total obligation, led by a $432.5 million Leidos Biomedical Research NIH facility operations award. The highest-conviction signal is Peraton Inc.'s $95.1 million CMS Fraud Prevention System 2 win, reflecting durable political support for healthcare fraud IT. A key risk is the August 2024 expiration of SOFTRAMS LLC's $80.7 million CMS IT contract, creating a potential revenue cliff for that small business. Overall, the digest signals stable, multi-year civilian IT and R&D spending, but with low margin upside due to cost-plus and fixed-price structures, and no defense sector catalysts.

5 total filings
· daily

Significant Contract Modifications ($10M+) — May 21, 2026

This digest covers $755.9 million in total obligations across five civilian agency contracts, with zero defense-related awards. The Department of Health and Human Services (HHS) dominates, accounting for four of five contracts and $685.3 million (91% of total value), led by a $432.5 million Leidos Biomedical Research GOCO facility operations award from NIH. The highest-conviction signal is Leidos' stable, multi-year cost-plus revenue stream, though only $1.15 million has been outlaid to date, signaling early-stage execution risk. A key watch item is the August 2024 expiration of SOFTRAMS LLC's $80.7 million CMS IT contract, which creates a potential revenue cliff for that small business. General Dynamics Information Technology's $70.6 million initial obligation on a $1.25 billion ceiling GSA IT contract provides long-term visibility but faces full-and-open competition pressure. No bearish signals were identified, but neutral ratings on three contracts reflect pricing risk, expiration cliffs, or minimal actual revenue recognition.

5 total filings
· daily

Contract Deobligations Alert — May 21, 2026

This digest covers $755.9 million in total obligations across 5 civilian agency contracts, with zero defense-related awards. The Department of Health and Human Services (HHS) dominates, accounting for $685.3 million (90.7%) of the total, led by a $432.5 million NIH GOCO facility operations contract to Leidos Biomedical Research and a $95.1 million CMS fraud prevention system award to Peraton. The highest-conviction signal is Leidos' stable, multi-year NIH revenue stream, though only $1.15 million has been outlayed to date, indicating early-stage execution risk. A key watch item is SOFTRAMS LLC's $80.7 million CMS IT contract expiring in August 2024, creating a potential revenue cliff for the small business. Overall, the digest reflects steady civilian IT and R&D spending but lacks the growth catalysts typical of defense contracts.

5 total filings
· daily

Contract Option Exercises — May 21, 2026

This digest covers $755.9 million in total obligations across 5 civilian contract actions, with zero defense-related awards, underscoring a concentrated non-DOD procurement theme. The dominant agency is the Department of Health and Human Services (HHS), accounting for 90.7% of total value via NIH, CMS, and BARDA awards. The highest-conviction signal is Leidos Biomedical Research's $432.5 million GOCO facility contract with NIH, providing a stable, multi-year revenue stream albeit with cost-plus margin constraints. A key risk is the upcoming August 2024 expiration of SOFTRAMS LLC's $80.7 million CMS IT contract, creating a potential revenue cliff for that small business. Overall, the digest points to steady civilian IT and life sciences R&D spending, but lacks the growth catalysts or margin upside typical of defense contracts.

5 total filings
· daily

Federal IT & Cybersecurity Contracts — May 21, 2026

This digest covers $246.4 million in total obligations across three civilian federal IT contracts, with zero defense-related awards. The dominant theme is healthcare IT modernization and fraud prevention at the Centers for Medicare and Medicaid Services (CMS), which accounts for $175.7 million (71%) of the total. The highest-conviction signal is Peraton Inc.'s $95.1 million Fraud Prevention System 2 award, a time-and-materials contract that provides stable, recurring revenue through 2026-2027 in a politically supported area. A key risk is SOFTRAMS LLC's $80.7 million contract expiring in August 2024, creating a potential revenue cliff if not renewed or recompeted.

3 total filings
· daily

All HHS Contracts — May 21, 2026

This digest covers $685.3 million in HHS contract obligations from May 21, 2026, with zero defense exposure, underscoring a pure civilian healthcare IT and life sciences R&D theme. The dominant signal is a $432.5 million Leidos Biomedical Research GOCO facility contract with NIH, representing 63% of total value and providing stable, multi-year cost-plus revenue. A $95.1 million Peraton fraud prevention contract with CMS adds a high-conviction, politically supported IT growth play. Key risks include a $80.7 million SOFTRAMS HUBZone contract expiring August 2024 (revenue cliff) and a $77.1 million Chimerix BARDA contract that was largely unfunded, highlighting execution risk. The highest-conviction signal is Peraton's CMS Fraud Prevention System 2 award, given CMS's sustained focus on fraud reduction and the time-and-materials pricing flexibility.

4 total filings
· daily

Mega Contracts Monitor ($100M+) — May 21, 2026

This single-contract digest covers a $432.5 million civilian award from the National Institutes of Health (NIH) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., representing the entirety of the period's activity. The contract is a cost-plus-fixed-fee delivery order to operate a government-owned, contractor-operated (GOCO) R&D facility, signaling stable but margin-constrained revenue for Leidos. With zero defense-related awards, the digest highlights a pure civilian R&D services theme, contrasting with typical defense-heavy contract flows. The highest-conviction signal is the low pricing risk and multi-year duration through May 2026, though only $1.15 million has been outlayed to date, creating execution pace uncertainty. A key risk is the early-stage outlay rate, which must accelerate to realize the full $432.5 million value.

1 total filings
· daily

High-Value Federal Grants ($5M+) — May 21, 2026

This digest covers $755.9 million in high-value federal grants and contracts, all from civilian agencies (0% defense), with the Department of Health and Human Services (HHS) as the dominant buyer accounting for $685.3 million (90.7%) of the total. The highest-conviction signal is Leidos Biomedical Research's $432.5 million NIH GOCO facility contract, offering a stable, multi-year cost-plus revenue stream, though early-stage outlay (only $1.15M funded) warrants monitoring. A key risk is the upcoming expiration of SOFTRAMS LLC's $80.7 million CMS IT contract in August 2024, creating a potential revenue cliff for the small business. The digest reveals a civilian IT and life sciences R&D theme, with no defense exposure, and a mix of cost-plus and fixed-price structures that balance margin stability against execution risk.

5 total filings
· daily

General Federal Contracts — May 21, 2026

This digest covers $755.9 million in total obligations across 5 civilian contracts (0 defense-related), with the Department of Health and Human Services (HHS) as the dominant agency, accounting for $684.6 million (90.6%) of the total. The highest-conviction signal is Leidos Biomedical Research's $432.5 million NIH GOCO facility contract, providing a stable, multi-year revenue stream with low pricing risk. However, the digest reveals a key risk: two contracts (SOFTRAMS LLC and Chimerix) face near-term expiration or have minimal outlays, creating potential revenue cliffs or execution uncertainty. The absence of defense contracts underscores a civilian-heavy procurement environment, with HHS life sciences and IT modernization as the dominant sector themes. Investors should watch Peraton's CMS fraud prevention contract for expansion options and GDIT's EMITS 2 for option exercises as key catalysts.

5 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 21, 2026

The 25 filings reveal a bifurcated landscape. The dominant theme is the landmark $52B merger-of-equals between **AvalonBay (AVB)** and **Equity Residential (EQR)**, generating $125M in net synergies and creating the largest multifamily REIT. However, the sheer volume of 8 related filings signals both heightened management attention and potential shareholder skepticism, warranting close monitoring. Separately, **Applied Materials (AMAT)** posted exceptional results with net income up 45.5% YoY and EPS of $6.05, demonstrating robust semi-equipment demand, though operating cash flow growth lagged. At the other extreme, **Apple iSports Group** remains cash-negative with zero revenue and a widening deficit, a clear distress case. **Zoom Communications** showed a mixed picture: revenue grew 5.5% YoY and AI-user uptake surged 184%, but churn ticked up to 3.0%. Capital allocation patterns are split—Radian issued $8M in sign-on equity for a new CEO, while PSBD extended buybacks, and AMAT slowed repurchases sharply to $737M from $3.0B. Overall, the Technology sector shows pockets of strong operational momentum (AMAT, Zoom) alongside significant restructuring and capital reallocation events, creating actionable divergence.

16 high priority 9 medium 25 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 21, 2026

The 28 filings for the NASDAQ-100 intelligence stream are dominated by the landmark AvalonBay-Equity Residential merger of equals, a $69B transaction that reshapes the multifamily REIT landscape and signals a sector-wide push for scale amid a maturing market. Outside this mega-deal, the data reveals a stark divergence in corporate health: Applied Materials posted exceptional 45.5% net income growth, while Apple iSports Group faces a liquidity crisis with zero revenue and a near-zero cash balance. Capital allocation trends are mixed, with Alphabet tapping the yen bond market for $5.3B and Sun Communities divesting UK assets for $1.03B to refocus on North America. Insider activity is notably absent across most filings, but several companies show strong shareholder support for governance proposals. The period-over-period data highlights a clear 'barbell' market, where cash-rich tech giants and distressed micro-caps coexist, demanding a selective investment approach.

18 high priority 10 medium 28 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 21, 2026

The 50 filings for the S&P 500 Financials sector on May 21, 2026, reveal a sector bifurcated between those executing strategic transformations and those facing acute liquidity stress. The most dominant theme is a wave of corporate restructuring, headlined by the $69 billion AvalonBay-Equity Residential merger of equals—the largest multifamily REIT combination ever—which signals a drive for scale and $175M in projected synergies. On capital allocation, we see contrasting patterns: Deere & Co. maintained a steady $4.5-5.0B guidance despite a 39% profit collapse in Production & Ag, while Shoe Carnival swung to a GAAP loss from $13.6M in transition charges. Period-over-period data shows 5 of the 8 operating companies with revenue or net income comparisons experienced declines or flat results, with Barnwell Industries posting a 29% revenue drop and a 184% cash burn increase. A cluster of 14 Puerto Rico closed-end funds announced strategic reviews to merge into open-end structures, indicating a sector-wide push for liquidity solutions. Insider and governance activity was notable: Rocket Pharmaceuticals saw 31.8% of votes withheld from a director, and Medallion Financial is in a proxy fight while boasting record earnings. Cash positions are eroding at smaller firms—Dalrada Financial saw cash plunge 52% to $82.6K—while larger entities like Cognizant accessed a $1B revolver. The overall picture is one of defensive positioning and portfolio optimization, with management teams acting decisively to address structural challenges.

27 high priority 23 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 21, 2026

The 50 filings from the S&P 500 Consumer Staples sector reveal a sector bifurcating between scale-driven leaders and challenged players. Walmart's strong Q1 FY27 (revenue +7.3% YoY, eCommerce +26%) contrasts with a sharp negative free cash flow swing (-$2.4B YoY), signaling aggressive investment. A major portfolio restructuring is underway as Kontoor Brands sells its Lee® business for up to $1B to focus on higher-growth brands, a move that will likely reshape the apparel landscape. Capital allocation is a key theme, with Kraft Heinz aggressively managing its balance sheet via a $1.1B debt tender, while Constellation Brands bolsters its board with top marketing talent from McDonald's. Insider activity is limited in this batch, but the Gabelli Dividend & Income Trust's proxy fight with Saba Capital Management highlights a broader activist push in closed-end funds, with performance data showing GDV up 29% in the last twelve months. Overall, the sector shows strong top-line growth for dominant players, but margin pressures from fuel costs and investment cycles are evident, creating a 'winners-take-most' dynamic.

19 high priority 31 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 21, 2026

The 50 filings from S&P 500 Industrials reveal a sector bifurcated between resilient capital-goods players and deeply distressed small-caps. Deere & Co. posted a 5% revenue increase but saw its Production & Precision Agriculture segment profit plunge 39%, while Advanced Drainage Systems reported 9.9% top-line growth but a 54% GAAP net income collapse due to acquisition costs. The most transformative event is the $69B AvalonBay/Equity Residential merger of equals, creating a multifamily REIT behemoth with $125M in net synergies. Capital allocation is defensive: Tractor Supply secured a new credit facility, Barnwell raised $3.4M via equity issuance, and Unity Bancorp maintained a $0.16 dividend. A wave of 14 Puerto Rico closed-end funds announced strategic reviews to convert to open-end structures, signaling a structural shift in that market. Insider activity is sparse but notable, with Nocopi Technologies insiders participating in a private placement alongside a transformative acquisition. The overarching theme is 'scale or die'—companies are using M&A and restructuring to navigate margin pressure while cash-strapped micro-caps like Dalrada face acute liquidity risk.

26 high priority 24 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 21, 2026

The S&P 500 Energy sector filings today reveal a bifurcated landscape: aggressive capital deployment into upstream acreage and midstream consolidation, contrasted with mixed operational performance and margin pressure. Devon Energy's $2.6B Delaware Basin acquisition at $161,500/acre signals strong conviction in Permian economics, while Baker Hughes' EC filing for the Chart Industries merger (expected July 2026) advances a transformative midstream deal. However, Copart's Q3 FY2026 results show domestic revenue stagnation (U.S. service revenues -2.1% YoY for nine months) offset by international strength (+11.4% YoY), and ONEOK's annual meeting confirmed stable governance. EOG Resources' doubling of its buyback authorization to $20B (with $2.9B remaining) underscores sector-wide capital return momentum, though Nocopi's dilutive $2.65M acquisition (500K shares issued) highlights small-cap execution risk. Insider activity is muted across filings, but the absence of selling in large caps is notable. Portfolio-level trends show capital discipline (buybacks > dividends) and a pivot toward high-return basin acreage, while margin compression in services (Copart U.S. operating income -0.5% YoY) warrants monitoring.

2 high priority 7 medium 9 total filings
· daily

US Material Events SEC 8-K Filings — May 21, 2026

The May 21, 2026, material events stream is dominated by transformative M&A and capital allocation activity, signaling a period of aggressive portfolio reshaping and strategic pivots across sectors. The $69 billion AvalonBay/Equity Residential merger of equals is the headline event, creating a multifamily REIT behemoth with $175 million in targeted synergies, though leadership transition risks and shareholder approval hurdles remain. Concurrently, we see a wave of capital market activity: Onto Innovation's $1.3B zero-coupon convertible offering (with a 50% conversion premium) and Trinity Capital's $300M note issuance highlight a bifurcated market where high-growth and credit-oriented firms are aggressively locking in low-cost, long-duration capital. A notable pattern of strategic divestitures and pivots is emerging, with Sun Communities selling its UK assets for $1.03B to refocus on North America, Skillsoft divesting Global Knowledge to sharpen its AI focus, and Hoth Therapeutics restructuring entirely into an AI semiconductor company. Insider and governance signals are mixed; while several companies are strengthening boards with high-profile talent (Constellation Brands, Veritone), others face significant shareholder dissent on compensation and equity plans (BankUnited, Rithm Capital), and a wave of CFO retirements and transitions (Erie Indemnity, Omega Healthcare, Skillsoft) introduces execution risk. The data reveals a market that is rewarding strategic clarity and financial engineering, while punishing governance lapses and unclear strategies.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 21, 2026

The 50 filings for Dow 30 constituents on May 21, 2026, are dominated by a single mega-deal: the $52B all-stock merger of equals between AvalonBay Communities and Equity Residential, creating the largest multifamily REIT in history with over 180,000 units. This transaction, covered across six separate filings, signals a defensive consolidation play in a maturing sector where geographic performance has diverged sharply. Beyond AvalonBay, the batch reveals a defensive tilt in capital allocation: S&P Global advances its Mobility spin-off (record date June 15, distribution July 1), Baker Hughes pushes its Chart Industries acquisition through EC review for a July close, and Advance Auto Parts reports its strongest comparable sales in five years (up 3.5%) alongside massive margin recovery (adjusted operating income up 410 bps YoY). However, red flags are flashing for smaller-cap names: Apple iSports Group has just $860 cash remaining with zero revenue, SpringBig Holdings lost board control to noteholders, and Hemab Therapeutics' cash burn is accelerating. Period-over-period data shows wide divergence—Walmart's e-commerce surged 26% globally while Barnwell Industries' revenue fell 29%, illustrating the bifurcation between scale-driven leaders and energy-exposed laggards.

25 high priority 25 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 21, 2026

Today's digest is dominated by two transformative mega-mergers in the real estate sector: AvalonBay Communities and Equity Residential's $69 billion all-stock merger of equals, and Sun Communities' $1.03 billion sale of its UK assets to refocus on North America. These deals signal a wave of consolidation and strategic refocusing in the REIT space. On the earnings front, Deere & Co. reported a mixed quarter with a 2% net income decline but maintained full-year guidance, while e.l.f. Beauty saw a sharp 76.5% net income drop despite 24.6% revenue growth due to acquisition-related charges. The biotech sector showed a stark contrast, with Immix Biopharma reporting a compelling 95% CR rate in a Phase 2 trial, while Brainstorm Cell Therapeutics filed for a dilutive offering with flat losses. A notable pattern is the surge in Puerto Rico closed-end funds (14 filings) announcing strategic reviews to convert to open-end structures, a significant liquidity event for a niche market. Overall, the day is characterized by high-conviction corporate actions, mixed earnings quality, and a cautious capital-raising environment for smaller companies.

27 high priority 23 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 21, 2026

The 50 filings for the S&P 500 Consumer Discretionary sector reveal a bifurcated landscape where discount retailers and value-oriented concepts are thriving, while other segments face margin pressure and liquidity concerns. Walmart and Ross Stores delivered standout quarters with strong revenue growth of 7.3% and 21% YoY respectively, driven by market share gains and value-seeking consumers, though Walmart's free cash flow turned sharply negative. e.l.f. Beauty reported robust 24.6% net sales growth but saw net income collapse 76.5% due to acquisition-related charges, highlighting the cost of aggressive M&A. The homebuilding sector saw a major unsolicited bid from Dream Finders Homes for Beazer Homes, signaling potential consolidation. Auto and restaurant filings were sparse, but Ford's DOE loan agreement for battery facilities indicates continued EV investment. A significant cluster of 14 Puerto Rico closed-end funds announced strategic reviews to convert to open-end structures, a major liquidity event for that market. Insider trading activity was minimal across filings, but several annual meetings revealed notable shareholder dissent on executive compensation, particularly at First Watch and Braemar Hotels.

25 high priority 25 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 21, 2026

The 32 filings in this S&P 500 Healthcare stream reveal a sector in transition, with strong operational performance at firms like Cirrus Logic (revenue +5.3% YoY, net income +25%) contrasting with acute distress at Dalrada Technology (revenue -44% YoY, negative equity). Capital allocation is active: News Corp authorized a $1B buyback, Broadridge raised its dividend, and Medallion Financial highlighted record earnings amid a proxy fight. M&A activity is notable with Columbia Financial/Northfield Bancorp merger and Greenland Mines' $35M acquisition. Insider trading is sparse, but the proxy contest at Medallion and withheld votes at Kingsway and HBT Financial signal governance concerns. Forward-looking catalysts include Jupiter Neurosciences' $2M offering for Parkinson's trial and NanoViricides' Ebola commentary. Overall, the sector shows bifurcation between profitable incumbents and cash-burning biotechs, with regulatory and shareholder activism risks.

8 high priority 24 medium 32 total filings